Target intelligence / Profile preview

Collagen type XXI alpha 1 chain (COL21A1)

Target
COL21A1
Molecular classification
Collagen superfamily, Fibril-associated collagens with interrupted triple helices (FACIT collagens), Extracellular matrix protein
01

Overview

Collagen type XXI alpha 1 chain is a structural protein encoded by the COL21A1 gene. It is part of the fibril-associated collagens with interrupted helices (FACIT) family, which contribute to the organization and integrity of the extracellular matrix. Type XXI collagen is localized to tissues containing type I collagen, including blood vessel walls, and is important for maintaining structural stability within the extracellular environment. Alternative splicing leads to multiple transcript variants. Pathway links involve the integrin signaling pathway and collagen trimerization, with some disease associations to certain renal carcinomas. There are currently no known direct drug interactions or targeting therapeutic approaches for this collagen chain. If more specific structural or functional data are needed—such as domain architecture—the protein contains domains like von Willebrand factor type A and thrombospondin-like N-terminal domains, characteristic of collagen superfamily members.

Other names
COL21A1Collagen, type XXI, alpha 1
02

Mechanism of action

Not applicable; no known drugs or direct pharmacological interventions targeting this protein

03

Biological functions

Maintenance of extracellular matrix integrityAssociation with type I collagen-containing tissues
04

Disease associations

Cancer (notably, Tfeb-rearranged renal cell carcinoma, renal cell carcinoma with MiT translocations)Potential implication in cocaine dependence (based on orthology and predictive data)
05

Safety considerations

None specifically noted, though off-target effects or ECM disruption could be relevant if targeted

Beyond the preview

Go deeper on Collagen type XXI alpha 1 chain (COL21A1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Collagen type XXI alpha 1 chain (COL21A1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call